略過巡覽連結
全部類別
照片
影音新聞
政府機關
國內公司行號
國外公司行號
非營利組織
中文稿
英文稿
有附件
無附件
受理採訪通知

會員登入

歡迎公司行號投遞新聞訊息(如文字、照片或活動預告等),詳洽業務行銷中心:
電話:886-2-2505-1180 轉780~786 或 790~797 傳真:886-2-2502-3805

NoTime標題
22 2018-04-19 14:43:37 EMQ Partners with Leading Vietnam Bank to Boost Remittance Capabilities across Southeast Asia
21 2018-04-19 13:37:07 ABB: Profitable Growth
20 2018-04-19 09:35:34 Red Bull Can You Make It? Teams Make It to the Finish Line in Amsterdam
19 2018-04-18 09:34:00 Egon Zehnder Asked over 400 of the World’s Top CEOs What They Found Harder Than Expected When They Took the Top Job. The Answer: the Human Side of the Role
18 2018-04-17 13:00:00 Gemalto to Protect 5G Next Generation Networks from Cyber-Attacks with Intel® Software Guard Extensions
17 2018-04-17 09:59:03 Boehringer Ingelheim and Lilly Announce an Academic Collaboration with University of Oxford to Investigate the Effects of Empagliflozin in People with Chronic Kidney Disease
16 2018-04-12 17:53:45 More than 2.5 billion records stolen or compromised in 2017
15 2018-04-12 09:16:32 Boehringer Ingelheim to invest €65 million in avian vaccines
14 2018-04-11 09:22:00 SES Accelerates Latin America’s Path to Ultra HD
13 2018-04-09 15:24:07 U.S. DoD Contracts Full O3b MEO Beam and Services from SES Government Solutions
12 2018-04-09 09:37:52 ABB to Invest €100 Million in Global Innovation and Training Campus
11 2018-04-09 09:36:56 Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.
10 2018-04-09 09:35:27 SES Shareholders Approve All Resolutions at Annual General Meeting
9 2018-04-09 09:35:23 Viewers in the Caribbean Gain Access to New, High-Quality TV Offer with Kiwisat and SES Video
8 2018-04-09 09:35:16 SES Appoints John-Paul Hemingway as CEO of SES Networks
7 2018-04-09 09:23:01 Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors
6 2018-04-09 09:15:12 SES Reaches 351 Million TV Homes Worldwide
5 2018-03-30 09:46:23 ABB Shareholders Approve All Proposals at Annual General Meeting
4 2018-03-30 09:45:59 Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine1
3 2018-03-28 09:32:17 Thales Launches Its Offer on All Gemalto Shares
2 2018-03-27 09:21:28 Three Leading Animal Health Companies Join Hands to Launch World-Class Vaccine Joint Venture Targeting Foot-and-Mouth Disease in China
1 2018-03-26 09:33:41 Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)

Top 中央社訊息平台首頁
新聞稿刊載服務請洽本社業務行銷中心人員,電話(02)2505-1180 轉 780 ~ 786 或 790 ~ 797 本平台資料均由投稿單位輸入後對外公布,資料如有錯誤、遺漏或虛偽不實,均由投稿單位負責
關閉提示
訊息提示
顯示提示